Skip to main content

Table 1 Clinical characteristics of 356 participants by sex

From: Area of the pressure-strain loop during ejection as non-invasive index of left ventricular performance: a population study

Characteristic

Men (n = 197)

Women (n = 159)

P value

Anthropometrics

 Age, y

53.2 ± 14.6

54.8 ± 12.5

0.27

 Body mass index, kg/m2

27.3 ± 3.56

26.5 ± 4.32

0.060

 Systolic BP, mm Hg

131.6 ± 14.8

129.3 ± 17.3

0.18

 Diastolic BP, mm Hg

85.3 ± 9.33

81.4 ± 8.85

< 0.0001

 Pulse pressure, mm Hg

46.3 ± 12.8

48.0 ± 13.8

0.23

 Mean arterial pressure, mm Hg

100.7 ± 9.72

97.4 ± 10.5

0.0020

 Heart rate, bpm

58.5 ± 8.98

60.6 ± 8.71

0.026

Questionnaire data

 Current smoking, n (%)

31 (15.7)

31 (19.5)

0.35

 Drinking alcohol, n (%)

119 (60.4)

37 (23.3)

< 0.0001

 Hypertensive, n (%)

100 (50.8)

69 (43.4)

0.17

 Treated for hypertension, n (%)

54 (27.4)

38 (23.9)

0.45

 β-blockers, n (%)

25 (12.7)

18 (11.3)

0.69

 ACE or ARB, n (%)

26 (13.2)

10 (6.3)

0.032

 CCB, n (%)

18 (9.1)

7 (4.4)

0.082

 Diuretics, n (%)

18 (9.1)

16 (10.1)

0.77

 History of diabetes, n (%)

8 (4.1)

8 (5.0)

0.66

Biochemical data

 Serum creatinine, μmol/L

81.6 ± 13.0

66.2 ± 17.9

< 0.0001

 Total cholesterol, mmol/L

4.84 ± 0.93

5.28 ± 0.96

< 0.0001

 Serum insulin, μmol/L

5.20 (2.20–12.0)

4.67 (2.00–10.7)

0.10

  1. Values are mean (±SD), number of subjects (%) or median (10–90% percentile interval). ACE indicates angiotensin-converting enzyme, ARB angiotensin-receptor blockers, bpm beats per minutes, CCB calcium channel blockers